Clinical Trials Details

TAPUR (Any Cancer)

Targeted Agent and Profiling Utilization Registry Study: A Phase II prospective non-randomized trial for patients with advanced cancer with an actionable genomic variant.

Objective

Key eligibility: Previous genomic testing.

» Learn more about the trial

Clinical Trial Categories

  • Cancers and Other Neoplasms